FDA Center for Drug Evaluation & Research Issues Warning Letter to Fantasy Face
April 08, 2026
April 08, 2026
WASHINGTON, April 8 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Guangzhou Huli Technology Co. Ltd. dba Fantasy Face from its Center for Drug Evaluation and Research:
* * *
Recipient: Haijie Long, Guangzhou Huli Technology Co., Ltd. dba Fantasy Face, 933 W 32nd St, Chicago, IL 60608, United States, lsj20250509@163.com
Issuing Office: Center for Drug Evaluation and Research (CDER), U . . .
* * *
Recipient: Haijie Long, Guangzhou Huli Technology Co., Ltd. dba Fantasy Face, 933 W 32nd St, Chicago, IL 60608, United States, lsj20250509@163.com
Issuing Office: Center for Drug Evaluation and Research (CDER), U . . .
